Your browser doesn't support javascript.
loading
MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort.
Pellegrini, Cristina; Botta, Francesca; Massi, Daniela; Martorelli, Claudia; Facchetti, Fabio; Gandini, Sara; Maisonneuve, Patrick; Avril, Marie-Françoise; Demenais, Florence; Bressac-de Paillerets, Brigitte; Hoiom, Veronica; Cust, Anne E; Anton-Culver, Hoda; Gruber, Stephen B; Gallagher, Richard P; Marrett, Loraine; Zanetti, Roberto; Dwyer, Terence; Thomas, Nancy E; Begg, Colin B; Berwick, Marianne; Puig, Susana; Potrony, Miriam; Nagore, Eduardo; Ghiorzo, Paola; Menin, Chiara; Manganoni, Ausilia Maria; Rodolfo, Monica; Brugnara, Sonia; Passoni, Emanuela; Sekulovic, Lidija Kandolf; Baldini, Federica; Guida, Gabriella; Stratigos, Alexandros; Ozdemir, Fezal; Ayala, Fabrizio; Fernandez-de-Misa, Ricardo; Quaglino, Pietro; Ribas, Gloria; Romanini, Antonella; Migliano, Emilia; Stanganelli, Ignazio; Kanetsky, Peter A; Pizzichetta, Maria Antonietta; García-Borrón, Jose Carlos; Nan, Hongmei; Landi, Maria Teresa; Little, Julian; Newton-Bishop, Julia; Sera, Francesco.
Afiliación
  • Pellegrini C; Department of Dermatology and Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
  • Botta F; Division of Epidemiology and Biostatistics, European Institute of Oncology IRCCS, Milan, Italy; Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy.
  • Massi D; Division of Pathological Anatomy, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy.
  • Martorelli C; Department of Dermatology and Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
  • Facchetti F; Pathology Section, Department of Molecular and Translational Medicine, Spedali Civili di Brescia, University of Brescia, Brescia, Italy.
  • Gandini S; Molecular and Pharmaco-Epidemiology Unit, Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.
  • Maisonneuve P; Division of Epidemiology and Biostatistics, European Institute of Oncology IRCCS, Milan, Italy.
  • Avril MF; APHP, Dermatology Department, Hôpital Cochin and Paris Descartes University, Paris, France.
  • Demenais F; Genetic Variation and Human Diseases Unit (UMR-946), Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France.
  • Bressac-de Paillerets B; Department of Biopathology and INSERM, University of Paris-Saclay, Villejuif, France.
  • Hoiom V; Department of Oncology and Pathology, Cancer Centre, Karolinska Institutet, Stockholm, Sweden.
  • Cust AE; Sydney School of Public Health and Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia.
  • Anton-Culver H; Department of Epidemiology, University of California, Irvine, CA, USA.
  • Gruber SB; USC Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
  • Gallagher RP; British Columbia Cancer and Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada.
  • Marrett L; Cancer Care Ontario, Toronto, ON, Canada.
  • Zanetti R; Piedmont Cancer Registry, Centre for Epidemiology and Prevention in Oncology in Piedmont, Turin, Italy.
  • Dwyer T; George Institute for Global Health, Nuffield Department of Obstetrics and Gynaecology, University of Oxford, Oxford, UK.
  • Thomas NE; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
  • Begg CB; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Berwick M; Department of Internal Medicine, University of New Mexico Cancer Center, University of New Mexico, Albuquerque, NM, USA.
  • Puig S; Melanoma Unit, Dermatology Department, Hospital Clinic Barcelona, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi I Sunyer, and CIBER de Enfermedades Raras, Barcelona, Spain.
  • Potrony M; Melanoma Unit, Dermatology Department, Hospital Clinic Barcelona, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi I Sunyer, and CIBER de Enfermedades Raras, Barcelona, Spain.
  • Nagore E; Department of Dermatology, Instituto Valenciano de Oncologia, Valencia, Spain.
  • Ghiorzo P; Department of Internal Medicine and Medical Specialties, University of Genoa and Ospedale Policlinico San Martino, Genoa, Italy.
  • Menin C; Diagnostic Immunology and Molecular Oncology Unit, Veneto Institute of Oncology, IOV-IRCCS, Padua, Italy.
  • Manganoni AM; Department of Dermatology, Spedali Civili di Brescia, University of Brescia, Brescia, Italy.
  • Rodolfo M; Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Brugnara S; Oncology Unit, Santa Chiara Hospital, Trento, Italy.
  • Passoni E; Department of Pathophysiology and Transplantation, University of Milan, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Sekulovic LK; Department of Dermatology, Faculty of Medicine, Military Medical Academy, Belgrade, Serbia.
  • Baldini F; Division of Melanoma, Sarcoma and Rare Cancer, European Institute of Oncology IRCCS, Milan, Italy.
  • Guida G; Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari Aldo Moro, Bari, Italy.
  • Stratigos A; 1st Department of Dermatology, Andreas Sygros Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Ozdemir F; Department of Dermatology, Faculty of Medicine, University of Ege, Izmir, Turkey.
  • Ayala F; Melanoma Unit, Cancer Immunotherapy and Innovative Therapies, IRCCS Istituto Nazionale dei Tumori, Fondazione G Pascale, Napoli, Italia.
  • Fernandez-de-Misa R; Dermatology Service, University Hospital Nuestra Senora de Candelaria, Santa Cruz de Tenerife, Spain.
  • Quaglino P; Dermatologic Clinic, Department of Medical Sciences, University of Torino, Turin, Italy.
  • Ribas G; Department of Medical Oncology and Haematology, Fundación Investigación Clínico de Valencia, INCLIVA Instituto de Investigación Sanitaria, Valencia, Spain.
  • Romanini A; US Ambulatori Melanomi, Sarcomi e Tumori Rari, UO Oncologia Medica 1, Azienda Ospedaliero-Universitaria Santa Chiara, Pisa, Italy.
  • Migliano E; Plastic Surgery, San Gallicano Dermatological Institute, IRCCS, Rome, Italy.
  • Stanganelli I; Skin Cancer Unit, IRCCS Scientific Institute of Romagna for the Study and Treatment of Cancer and University of Parma, Meldola, Italy.
  • Kanetsky PA; Department of Cancer Epidemiology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Pizzichetta MA; University of Trieste, Centro di Riferimento Oncologico, IRCCS, Aviano, Italy.
  • García-Borrón JC; Department of Biochemistry, Molecular Biology, and Immunology, University of Murcia and IMIB-Arrixaca, Murcia, Spain.
  • Nan H; Department of Epidemiology, Richard M Fairbanks School of Public Health, Melvin & Bren Simon Cancer Center, Indiana University, Indianapolis, IN, USA.
  • Landi MT; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Little J; School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada.
  • Newton-Bishop J; Section of Epidemiology and Biostatistics, Institute of Medical Research at St James', University of Leeds, Leeds, UK.
  • Sera F; Department of Public Health, Environments and Society, London School of Hygiene & Tropical Medicine, London, UK.
Lancet Child Adolesc Health ; 3(5): 332-342, 2019 05.
Article en En | MEDLINE | ID: mdl-30872112
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Biomarcadores de Tumor / Mutación de Línea Germinal / Receptor de Melanocortina Tipo 1 / Melanoma Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Child Adolesc Health Año: 2019 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Biomarcadores de Tumor / Mutación de Línea Germinal / Receptor de Melanocortina Tipo 1 / Melanoma Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Child Adolesc Health Año: 2019 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido